Evidence map›Paper›PMID 26246484›Full record

ArticleJournal of clinical microbiology2015

Application of Isothermal Amplification Techniques for Identification of Madurella mycetomatis, the Prevalent Agent of Human Mycetoma.

Sarah A Ahmed, Wendy W J van de Sande, Marie Desnos-Ollivier, Ahmed H Fahal, Najwa A Mhmoud, G S de Hoog

Abstract readComparative StudyEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Host genetic susceptibility to mycetoma.PLoS neglected tropical diseases · 2020
    Pooled it
  2. Mycetoma.PLoS neglected tropical diseases · 2026
    Review
  3. The development of a multiplex recombinase polymerase amplification reaction to detect the most common causative agents of eumycetoma.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. A scoping review of mycetoma profile in Egypt: revisiting the global endemicity map.Transactions of the Royal Society of Tropical Medicine and Hygiene · 2023
    Article
  11. Diagnostics to support mycetoma management-Development of two target product profiles.Tropical medicine & international health : TM & IH · 2022
    Article
  12. Article
  13. Article
  14. Mycetoma: Development of Diagnosis and Treatment.Journal of fungi (Basel, Switzerland) · 2022
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Identification of Mycoses in Developing Countries.Journal of fungi (Basel, Switzerland) · 2019
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sarah A AhmedFaculty of Medical Laboratory Sciences, University of Khartoum, Khartoum, Sudan CBS-KNAW Fungal Biodiversity Centre, Utrecht, Netherlands Institute for Biodiversity and Ecosystem Dynamics, University of Amsterdam, Netherlands.
Wendy W J van de SandeErasmus MC, Department of Medical Microbiology and Infectious Diseases, Rotterdam, Netherlands.
Marie Desnos-OllivierInstitut Pasteur, Unité de Mycologie Moléculaire, Centre National de Référence Mycologie et Antifongiques, Paris, France.
Ahmed H FahalMycetoma Research Centre, University of Khartoum, Khartoum, Sudan.
Najwa A MhmoudMycetoma Research Centre, University of Khartoum, Khartoum, Sudan.
G S de HoogPeking University Health Science Center, Research Center for Medical Mycology, Beijing, China Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China Shanghai Institute of Medical Mycology, Changzheng Hospital, Second Military Medical University, Shanghai, China Basic Pathology Department, Federal University of Paraná State, Curitiba, Paraná, Brazil King Abdulaziz University, Jeddah, Saudi Arabia s.hoog@cbs.knaw.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Appropriate diagnosis and treatment of eumycetoma may vary significantly depending on the causative agent. To date, the most common fungus causing mycetoma worldwide is Madurella mycetomatis. This species fails to express any recognizable morphological characteristics, and reliable identification can therefore only be achieved with the application of molecular techniques. Recombinase polymerase amplification (RPA) and loop-mediated isothermal amplification (LAMP) are proposed as alternatives to phenotypic methods. Species-specific primers were developed to target the ribosomal DNA (rDNA) internal transcribed spacer (ITS) region of M. mycetomatis. Both isothermal amplification techniques showed high specificity and sufficient sensitivity to amplify fungal DNA and proved to be appropriate for detection of M. mycetomatis. Diagnostic performance of the techniques was assessed in comparison to conventional PCR using biopsy specimens from eumycetoma patients. RPA is reliable and easy to operate and has the potential to be implemented in areas where mycetoma is endemic. The techniques may be expanded to detect fungal DNA from environmental samples.

Indexed as

DNA, FungalDNA PrimersDNA, Ribosomal SpacerHumansMadurellaMolecular Diagnostic TechniquesMycetomaNucleic Acid Amplification TechniquesSensitivity and SpecificityDNA, FungalDNA PrimersDNA, Ribosomal Spacer

Identifiers

PMID26246484
PMCPMC4572522

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.